ZARZA We are Zarza, the prestigious firm behind major projects in information technology.

RopesTalk

RopesTalk

Por: Ropes & Gray LLP

Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.

478 episodios disponibles

Latest episodes of the podcast RopesTalk

Mostrando página 21 de 24

ESG Considerations for Asset Managers in Light of the COVID-19 Pandemic 18/05/2020

Credit Funds: Considerations for Credit Fund Managers Overseeing ERISA Plan Assets in Light of the COVID-19 Pandemic 13/05/2020

The Intersection of Private and Registered Funds: Interval Fund Investments in Private Open-End Real Estate Funds 12/05/2020

Preferred Equity Financings: Tools for Both Fund Sponsors and Investors 07/05/2020

Building a Sanctions Compliance Programme 28/04/2020

Culture & Compliance Chronicles: Incorporating Behavioral Science in Audit & Monitoring 28/04/2020

Proposed Amendments to the Volcker Rule's Covered Fund Provisions 27/04/2020

TALF 2.0: Anticipating the 2020 Term Asset-Backed Securities Loan Facility Program 20/04/2020

Recent Developments in Credit Funds Secondaries: Has the COVID-19 Pandemic Introduced New Opportunities? 15/04/2020

Culture & Compliance Chronicles: Behavioral Science—The Audit & Monitoring Perspective 02/04/2020

Key Decisions for Defined Contribution Plan Sponsors Under the CARES Act 01/04/2020

Cross-selling in the Crosshairs: Implications and Challenges of the Oracle 401(k) Fee Litigation Settlement 23/03/2020

Alumni @ RopesTalk: Conversation with Alex Roberts, UNH Law 18/03/2020

COVID-19 and Derivatives Trading Agreements: Considerations for the Buy-Side 16/03/2020

CFIUS Update: Key Takeaways from the FIRRMA Implementing Regulations 05/03/2020

ACES Compliance Summit: Conversation with Momentum Events 14/02/2020

Alumni @ RopesTalk: Conversation with Jennifer Bealer, Progyny 12/02/2020

Questions & Concerns About Documentation: A Conversation with Colin Adams, M3 Partners 12/02/2020

ESMA Report: Undue Pressure on Companies 27/01/2020

Non-binding Guidance: SEC Disclosure Issues for Life Sciences Companies 09/01/2020

« Primera ‹ Anterior 1 ... 19 20 21 22 23 24 Siguiente › Última »